Risk of Clostridium difficile Infection in Hematology-Oncology Patients Colonized With Toxigenic C. difficile

Cara Cannon, Jackson Musuuza, Anna Barker, Megan Duster, Mark Juckett, Aurora Pop‐Vicas, Nasia Safdar

Infection Control and Hospital Epidemiology · 2017 · 33 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile infection control interventions. Infect Control Hosp Epidemiol 2017;38:718-720.

References

8